Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Watanabe

Showing results (421-430 of 510) with videos related to

Pageof 51
Sort By:
Scientific Reports|April 7, 2019
Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patientsSayuri Nitta, Yasuhiro Asahina, Takanobu Kato, et al.
Journal of Crohn'S & Colitis|August 28, 2016
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized TrialTakayuki Matsumoto, Satoshi Motoya, Kenji Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 24, 2002
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppressionNobuhiko Kanazawa, Namiki Izumi, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Journal of Gastroenterology|April 23, 2013
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Journal of Gastroenterology|July 18, 2013
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Anticancer Research|March 28, 2023
Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/TipiracilItaru Hashimoto, Kazuki Kano, Shizune Onuma, et al.
Journal of Personalized Medicine|June 28, 2023
Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/TipiracilItaru Hashimoto, Kazuki Kano, Shizune Onuma, et al.
Biochemical and Biophysical Research Communications|December 13, 2016
Indispensable role of Notch ligand-dependent signaling in the proliferation and stem cell niche maintenance of APC-deficient intestinal tumorsToru Nakata, Hiromichi Shimizu, Sayaka Nagata, et al.
Data in Brief|January 27, 2017
Data showing proliferation and differentiation of intestinal epithelial cells under targeted depletion of Notch ligands in mouse intestineToru Nakata, Hiromichi Shimizu, Sayaka Nagata, et al.
Pageof 51

Showing results (421-430 of 510) with videos related to

Sort By:
Pageof 51
Scientific Reports|April 7, 2019
Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patientsSayuri Nitta, Yasuhiro Asahina, Takanobu Kato, et al.
Journal of Crohn'S & Colitis|August 28, 2016
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized TrialTakayuki Matsumoto, Satoshi Motoya, Kenji Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 24, 2002
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppressionNobuhiko Kanazawa, Namiki Izumi, Kaoru Tsuchiya, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Journal of Gastroenterology|April 23, 2013
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Journal of Gastroenterology|July 18, 2013
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis CYasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, et al.
Anticancer Research|March 28, 2023
Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/TipiracilItaru Hashimoto, Kazuki Kano, Shizune Onuma, et al.
Journal of Personalized Medicine|June 28, 2023
Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/TipiracilItaru Hashimoto, Kazuki Kano, Shizune Onuma, et al.
Biochemical and Biophysical Research Communications|December 13, 2016
Indispensable role of Notch ligand-dependent signaling in the proliferation and stem cell niche maintenance of APC-deficient intestinal tumorsToru Nakata, Hiromichi Shimizu, Sayaka Nagata, et al.
Data in Brief|January 27, 2017
Data showing proliferation and differentiation of intestinal epithelial cells under targeted depletion of Notch ligands in mouse intestineToru Nakata, Hiromichi Shimizu, Sayaka Nagata, et al.
Pageof 51